2015 Trumbull Memorial Hospital Demo

Ondansetron (Zofran) Ondansetron (Zofran ® )

Action

Onset Rapid

Antiemetic

Indications Nausea / Vomiting

Adult Dose 4 mg IVP/IO/IM/ODT Repeatable once to maximum of 8mg IVP/IO/IM/ODT in adults

Pediatric Dose 1 month to 12 years old

< 30kg/66lbs: 0.1 mg/kg IV/IO x 1 or ½ ODT > 30kg/66lbs: 4 mg IV/IO/ODT, Maximum 4 mg

Contraindications Hypersensitivity

Adverse Reactions Headache, dizziness, diarrhea, constipation, fever, pruritis, dry mouth, increased liver function tests, malaise, fatigue, anaphylaxis, ECG alterations: arrhythmias, prolonged PR, QRS, and QTI Precautions Not a drug that stimulates gastric or intestinal peristalsis. Transient ECG changes including QTI prolongation. Use with caution in nursing women.

215

EMR

EMT

AEMT

Paramedic

Extended